Analysis of Four New Enterococcus faecalis Phages and Modeling of a Hyaluronidase Catalytic Domain from Saphexavirus .
Gustavo Di LalloMattia FalconiFederico IacovelliDomenico FrezzaPietro D'AddabboPublished in: PHAGE (New Rochelle, N.Y.) (2021)
Background: Phage therapy (PT), as a method to treat bacterial infections, needs identification of bacteriophages targeting specific pathogenic host. Enterococcus faecalis , a Gram-positive coccus resident in the human gastrointestinal tract, may become pathogenic in hospitalized patients showing acquired resistance to vancomycin and thus representing a possible target for PT. Materials and Methods: We isolated four phages that infect E. faecalis and characterized them by host range screening, transmission electron microscopy, and genome sequencing. We also identified and three-dimensional modeled a new hyaluronidase enzyme. Results: The four phages belong to Siphoviridae family: three Efquatrovirus (namely vB_EfaS_TV51, vB_EfaS_TV54, and vB_EfaS_TV217) and one Saphexavirus (vB_EfaS_TV16). All of them are compatible with lytic cycle. vB_EfaS_TV16 moreover presents a gene encoding for a hyaluronidase enzyme. Conclusions: The identified phages show features suggesting their useful application in PT, particularly the Saphexavirus that may be of enhanced relevance in PT because of its potential biofilm-digestion capability.
Keyphrases
- hyaluronic acid
- electron microscopy
- pseudomonas aeruginosa
- recombinant human
- endothelial cells
- genome wide
- staphylococcus aureus
- gene expression
- candida albicans
- single cell
- biofilm formation
- dna methylation
- stem cells
- gram negative
- multidrug resistant
- methicillin resistant staphylococcus aureus
- transcription factor
- mesenchymal stem cells
- quality improvement
- drug delivery
- induced pluripotent stem cells
- anaerobic digestion
- bone marrow